Polyunsaturated Fatty Acids For Multiple Sclerosis Treatment: Scientific Evidence

INTRODUCTIONFatty acids have an important role in structure and function of the nervous system. Recently, epidemiologic studies on neurodegenerative disorders have evaluated the usefulness of polyunsaturated fatty acids on multiple sclerosis.OBJECTIVETo examine recent studies, clinical trials, and reviews on the therapeutic effect of polyunsaturated fatty acids in multiple sclerosis.METHODSWe conducted a search in Pubmed/Medline and Cochrane Library with the terms "fatty acids", "omega3" and "omega-6" in combination with "multiple sclerosis". Articles were selected according to their relevance on the topic.RESULTSEpidemiologic studies have shown benefits of dietary supplementation with polyunsaturated fatty acids - especially omega-3-in relation to inflammatory, autoimmune and neurodegenerative disorders. In contrast, the studies do not show a beneficial effect of polyunsaturated fatty acids in multiple sclerosis. However, the studies have limitations related to design and sample issues.CONCLUSIONSThere is some evidence of a protective effect of polyunsaturated fatty acids on the risk of multiple sclerosis. Despite of this, to date controlled trials have not produced definite results on the benefits of supplementation with polyunsaturated fatty acids in patients with multiple sclerosis. Any potential benefit will have to be confirmed in the long term.